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Improvement in the active management of
the third stage of labor for the prevention
of postpartum hemorrhage in Tanzania: a
cross-sectional study
Dunstan R. Bishanga1,3* , John Charles5, Gaudiosa Tibaijuka1, Rita Mutayoba6, Mary Drake1, Young-Mi Kim2,
Marya Plotkin2, Neema Rusibamayila4 and Barbara Rawlins2
Abstract
Background: Tanzania has a maternal mortality ratio of 556 per 100,000 live births, representing 21% of all deaths of
women of reproductive age. Hemorrhage, mostly postpartum hemorrhage (PPH), is estimated to cause at least 25% of
maternal deaths in Tanzania. In 2008, the Ministry of Health, Community Development, Gender, Elderly and Children
launched interventions to improve efforts to prevent PPH. Competency-based training for skilled birth attendants and
ongoing quality improvement prioritized the practice of active management of the third stage of labor (AMTSL).
Methods: A cross-sectional study was conducted in 52 health facilities in Tanzania utilizing direct observations of
women during labor and delivery. Observations were conducted in 2010 and, after competency-based training and
quality improvement interventions in the facilities, in 2012. A total of 489 deliveries were observed in 2010 and 558 in
2012. Steps for AMTSL were assessed using a standardized structured observation checklist that was based on World
Health Organization guidelines.
Results: The proportion of deliveries receiving all three AMTSL steps improved significantly by 19 percentage points (p
< 0.001) following the intervention, with the most dramatic increase occurring in health centers and dispensaries (47.2
percentage point change) compared to hospitals (5.2 percentage point change). Use of oxytocin for PPH prevention
rose by 37.1 percentage points in health centers and dispensaries but remained largely the same in hospitals, where
the baseline was higher. There was substantial improvement in the timely provision of uterotonics (within 3 min of
birth) across all facilities (p = 0.003). Availability of oxytocin, which was lower in health centers and dispensaries than
hospitals at baseline, rose from 73 to 94% of all facilities.
Conclusion: The quality of PPH prevention increased substantially in facilities that implemented competency-based
training and quality improvement interventions, with the most dramatic improvement seen at lower-level facilities. As
Tanzania continues with efforts to increase facility births, it is imperative that the quality of care also be improved by
promoting use of up-to-date guidelines and ensuring regular training and mentoring for health care providers so that they
adhere to the guidelines for care of women during labor. These measures can reduce maternal and newborn mortality.
Keywords: Postpartum hemorrhage, Quality of care, Active management of the third stage of labor, AMTSL, Uterotonic,
Obstetric complications, Tanzania
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Background
Globally, maternal mortality is a major public health prob-
lem, with an estimated 303,000 deaths occurring in 2015.
Sub-Saharan Africa accounted for 195,000—or almost
two-thirds—of those deaths [1]. Tanzania is a substantial
contributor to maternal mortality, with a maternal mortal-
ity ratio of 556 per 100,000 live births during the 10-year
period before the 2015/2016 Demographic and Health
survey. Maternal mortality accounts for 21% of deaths of
women of reproductive age [2]. Maternal mortality in
Tanzania has not significantly changed over the last dec-
ade despite a positive trend in institutional deliveries,
which rose from 47% in 2004 to over 60% in 2015 [2–4].
This gap suggests the urgent need to improve quality of
care in health facilities to reduce maternal and perinatal
morbidity and mortality, particularly around labor and de-
livery and the immediate postnatal period [5].
Studies have shown that improving the quality of care
can address obstetric complications and reduce preventable
perinatal and maternal deaths [6–9]. The World Health
Organization (WHO) defines quality of care as “the extent
to which health care services provided to individuals and
patient populations improve desired health outcomes. In
order to achieve this, health care must be safe, effective,
timely, efficient, equitable and people-centered” [8]. WHO
supports the provision of high-quality intrapartum care to
save lives through use of up-to-date guidelines and stan-
dards. Evidence-based practices for routine care and man-
agement of complications form part of the eight domains
in the WHO quality-of-care framework for maternal and
newborn health [5].
Obstetric hemorrhage remains the leading cause of ma-
ternal mortality in low-income countries; it accounts for
up to 34% of maternal deaths in Africa [10] and at least
one-fourth of maternal deaths in Tanzania [11, 12]. Despite
the fact that it is largely preventable, postpartum
hemorrhage (PPH) is the most common and most deadly
form of obstetric bleeding [13]. One assessment found that
PPH was the second leading cause of maternal deaths at
Muhimbili National Hospital in Dar es Salaam [14]. The
main PPH prevention measure recommended in low- and
middle-income countries (LMICs) is active management of
the third stage of labor (AMTSL), which WHO recom-
mends for all deliveries, in LMIC settings [15]. As defined
in 2003 by the International Confederation of Midwives
(ICM) and International Federation of Gynecology and
Obstetrics (FIGO), AMTSL had three main components:
(1) administration of a uterotonic within 1 min of birth
(the “relaxed” definition is within 3 min of birth); (2) deliv-
ery of the placenta by controlled cord traction (CCT); and
(3) uterine massage [16]. In 2012, WHO revised the defin-
ition to emphasize provision of uterotonic (preferably oxy-
tocin) in the third stage of labor [15, 17]; CCT and
sustained uterine massage are no longer recommended for
uncomplicated deliveries. Continued monitoring of the
uterus for 2 h after birth is recommended, with fundal
massage if the uterus is soft [17].
There is a dearth of published information on the ob-
served quality of delivery care in low-income countries,
and few studies include observations of actual PPH pre-
vention care. A study in seven countries (Benin,
Ethiopia, Tanzania, Indonesia, El Salvador, Honduras,
and Nicaragua) conducted by Stanton et al. in 2005–
2006 used direct observation to assess AMTSL and
found correct use in 1.7 to 39.6% of deliveries in each
country, with Tanzania being among the lowest; this ana-
lysis used the ICM-FIGO definition of AMTSL, with
timing relaxed to 3 min [18]. In 2009, Mfinanga et al.
re-analyzed the Tanzanian data from this study to ac-
count for data collection problems and changing defini-
tions of ergometrine dosages. They found that correct
practice of AMTSL was 17%, using the relaxed definition
and recommended uterotonic at the time (i.e., ergomet-
rine within 3 min of delivery) [19]. More recently, Bart-
lett et al. reported substantial variations in the use of
AMTSL within 3 min of birth in six sub-Saharan coun-
tries; direct observation of facility-based AMTSL found
that correct use ranged from 28 to 62% across these
countries and was 42% for Tanzania. The Tanzania find-
ing draws on the same 2010 data as the current study
but includes Zanzibar; the analysis presented in this
paper is limited to the Tanzania mainland [20].
In 2008 the Ministry of Health, Community Development,
Gender, Elderly and Children (MoHCDGEC) (formerly the
Ministry of Health and Social Welfare) adopted routine use
of AMTSL in all deliveries for PPH prevention. The proto-
col recommends oxytocin as the preferred uterotonic, with
ergometrine and misoprostol recommended where oxytocin
is not available [11]. Routine provision of AMTSL was sub-
sequently scaled up by the ministry and implementing part-
ners, including the Mothers and Infants Safe, Healthy, Alive
(MAISHA) program, a 5-year program funded by the
United States Agency for International Development
(USAID) and led by Jhpiego. The MAISHA program sought
to improve the quality of maternal and newborn care by
providing competency-based training for health care pro-
viders and a quality improvement intervention for maternal
and newborn health services.
The MAISHA program, with support from the Ma-
ternal and Child Health Integrated Program, conducted
a cross-sectional study using direct observations of de-
liveries to assess the quality of key elements of mater-
nal and newborn care in selected health facilities in 12
regions of Tanzania and to evaluate the intervention.
Observations were conducted in 2010 and then re-
peated in 2012 after competency-based training and
quality improvement interventions were implemented
in the facilities.
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This paper compares the two rounds of observations to
provide an in-depth assessment of the quality of PPH pre-
vention services in Tanzania before and after a quality im-
provement program. Thus, it not only provides critical
insight into the state of PPH preventative services but also
contributes to evidence on the potential impact of quality
improvement programs on specific areas of intrapartum
care. The study results will be useful for policy makers,
program planners, and key stakeholders in improving the
quality of intrapartum care in the LMIC setting.
Methods
Study design
A cross-sectional health facility assessment using direct
observations of the quality of care during labor and deliv-
ery was conducted in 12 of Tanzania’s 31 regions (Tanga,
Mtwara, Lindi, Arusha, Kilimanjaro, Morogoro, Manyara,
Tabora, Pwani, Kigoma, Ruvuma and Iringa) in 2010 and
2012. These included all Phase 1 regions of the MAISHA
program, which was eventually rolled out to the rest of
the country. Quality improvement interventions were in-
troduced shortly before the 2010 study, which was
intended to be a baseline assessment. The 2012 assess-
ment was designed to examine the effects of the MAISHA
program interventions. The 2010 assessment included 52
facilities: 12 hospitals and 40 health centers and dispensar-
ies. Two lower-level facilities were dropped from the 2012
assessment because they did not receive interventions as
planned due to staffing challenges.
Interventions to improve quality of PPH services in
MAISHA program sites
The MAISHA program provided technical assistance to
the MoHCDGEC to develop and disseminate standard-
ized maternal and newborn health care guidelines based
on WHO recommendations, including for PPH preven-
tion. The program developed clinical standards and
training materials, including PPH prevention job aids.
The program also provided support at central and local
levels to roll out the guidelines and learning resources.
Results from the baseline assessment were disseminated
to key stakeholders and joint action plans were devel-
oped locally with facility and district teams. The plans
were designed to address gaps identified in the provision
of high-quality care.
Capacity building was a core component of the program,
which sought to equip service providers, supervisors and
managers with knowledge, attitudes and skills to enable
provision of quality maternal care according to established
standards. The program facilitated competency-based train-
ing, coaching and mentoring to strengthen the provision of
routine maternal and newborn care, including the adminis-
tration of uterotonics as part of AMTSL and emergency
obstetric care (EmOC) signal functions that address
management of PPH. Providers in target facilities received
supervision and coaching on a quarterly basis, with gaps in
skills addressed on site by trained supervisors. The mean
length of the MAISHA program in these facilities was
25 months, with a range of 17 to 41 months.
Under the MAISHA program, facilities formed quality
improvement teams (QITs), which received training and
ongoing supportive supervision and mentorship. QITs in-
cluded representatives from different departments within
the facility and used the Standards-Based Management
and Recognition approach, which utilizes a “Plan-Do-Stu-
dy-Act” cycle to improve the quality of maternal and new-
born care [21]. Subsequently, the QITs facilitated quality
circles, referred to as work improvement teams (WITs),
which used a participatory management technique that
enlists the help of health care providers in solving prob-
lems related to the provision of care. WITs included staff
providing care in labor and delivery wards, antenatal and
postnatal wards and antenatal clinics. Both teams met
regularly to assess actual performance against desired per-
formance, identify performance gaps, select solutions to
improve performance and prepare action plans to imple-
ment the performance-improvement solutions (Fig. 1).
Trained external assessors from the MAISHA program
and MoHCDGEC performed facility assessments annu-
ally or upon request by facility staff/management. Facil-
ities that achieved an 80% score on maternal and
newborn clinical performance standards were formally
recognized by the MoHCDGEC.
The program trained and provided quality improve-
ment support to 1593 providers and supervisors. Add-
itionally, key health managers at regional, district and
facility levels were oriented on the quality improvement
tools so they could support the WITs. The program
trained 921 service providers in EmOC, including
AMTSL, in the 52 facilities. Providers of maternity ser-
vices who did not receive training initially were reached
through onsite supervision and mentorship.
Sampling
The sampling of facilities was done purposively and in-
cluded regional hospitals, health centers and dispensar-
ies. Inclusion criteria for health centers and dispensaries
included conducting at least one delivery per day. Two
health centers were subsequently dropped from the
MAISHA program due to inadequate staffing, so that
only 50 facilities were reassessed in 2012.
This study was designed to capture change in AMTSL
practice by estimating the number of deliveries that
needed to be observed to see a change of up to 50% in
the provision of AMTSL. We used the Prevention of
Postpartum Hemorrhage Initiative national survey
(POPPHI-2006) as the basis for the proportion of
women who correctly received AMTSL, using the
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FIGO/ICM definition with a uterotonic administered
within 1 min of delivery. This value was 7% [22]. Assum-
ing a change of up to 50% in the practice, with a desired
power of 80% and precision of 95%, the sample needed
to include observations of 449 deliveries.
Data collection tools and procedure
Data collectors used standardized tools, including the
Service Provision Assessment’s provider interview guide
and WHO’s clinical guidelines [23]. The routine labor
and delivery clinical observation checklist was adapted
from an instrument used by Stanton et al. [18].
A daily quota of deliveries to be observed during the
2- to 4-day data collection period was calculated per fa-
cility, based upon the expected number of deliveries per
day at that facility. Women admitted for an emergency
caesarean section were not observed, nor were those
who needed caesarean section after the start of labor.
The following procedures were used during data
collection:
1. Observations of labor and delivery: In each
health facility, trained data collectors used a
structured observation checklist to observe and
document care provided to women giving birth
(Additional file 1). Data collectors observed any
provider working at the time of the assessment,
regardless of whether or not they had received
training under the MAISHA program. Data
collectors observed key steps in the provision
of care to women with uncomplicated
deliveries. The first stage of labor involved
intermittent observation, while the second and
third stages of labor involved continuous
observation until one hour after birth.
Performance or non-performance of each com-
ponent of AMTSL was documented, including
the type of uterotonic used.
2. Facility audit/inventory for presence of
uterotonic drugs (Additional file 2): A
standardized audit was conducted to assess selected
components of facility readiness; the audit included
both the maternity ward and facility pharmacy
(drug storage rooms). Data collectors visually
confirmed the presence of at least one dose of
oxytocin, ergometrine and/or misoprostol in the
maternity ward and checked the drug expiry date;
expired drugs were excluded from the inventory.
Any field missing a value was assumed to indicate
the absence of the drug.
Data collectors were selected from a pool of national
basic emergency obstetric and newborn care trainers.
They underwent a two-week training on study methods,
research ethics and observation practices using the study
tools and tablets. Inter-rater reliability was assessed dur-
ing training and repeated until the observers had a high
level of agreement. The training also included clinical
updates on intrapartum and immediate postpartum care
and 2 days of practice using the tools in two non-study
health facilities. To reduce bias, data collectors were
assigned to study sites where they had never worked or
conducted training. Fourteen of the 20 data collectors
employed in 2012 had also participated in the 2010 data
collection.
Data collectors entered observations and other data
into tablets (Samsung Galaxy with Mobile Data Stu-
dio software) that were pre-populated with the data
collection forms. The observers could observe mul-
tiple deliveries at the same time by flipping between
files. No more than three deliveries were observed at
any given time.
Data management
The data entry applications on the tablet controlled
question flow, data skips along with range, consistency
Fig. 1 Cycle of performance improvement
Bishanga et al. BMC Pregnancy and Childbirth  (2018) 18:223 Page 4 of 10
and data quality checks. Every evening, supervisors
would transfer data to the server. Upon receipt, further
quality checks were performed before porting the
cleaned data over to an SQL Server database with a
password-protected web portal for analyzing and dis-
playing the data.
Analysis
Variables were created based on “yes, observed”/ “no, not
observed” responses to observational checklist items, with
“don’t know” responses excluded. Stata Statistical Software
12.0 was used to analyze data to generate descriptive sta-
tistics, including means and frequencies. Cross-tabulations
using chi-square tests of significance were used to com-
pare quality-of-care indicators between 2010 and 2012.
Post-stratification weights were applied to labor and deliv-
ery observations to account for differences between the
numbers of observed and expected cases based on health
management information system records of health facility
caseloads of deliveries. A p value of 0.05 was considered
statistically significant in all analyses.
The AMTSL components’ analysis was based on the
FIGO/ICM AMTSL definition, which was widely used in
2008 at the conception of the study. We analyzed ad-
ministration within 1 min of birth (per the FIGO/ICM
definition) and within 3 min (per the “relaxed” defin-
ition). Analyses of timing of uterotonic administration
were based on observers’ recording of the exact times.
Missing/invalid values were assumed to not adhere to ei-
ther the 1-min or 3-min guidelines.
Results
Sample of observed deliveries
A total of 489 deliveries were observed at 52 health facil-
ities (12 hospitals and 40 lower-level health facilities) in
2010, and 558 deliveries were observed at 50 of these
same facilities (12 hospitals and 38 lower-level facilities)
in 2012 (Table 1). In 2010, of the 415 women who were
observed during the third stage of labor, 403 received
any uterotonic (97.1%); in 2012, of the 502 women who
were observed during the third stage of labor, 451 re-
ceived any uterotonic (89.8%). The proportion of women
receiving any uterotonic regardless of timing fell by 7.3
percentage points between 2010 and 2012, which was
not statistically significant (data not shown).
Frequency and quality of provision of AMTSL
The provision of all three steps of AMTSL (uterotonic,
CCT, and uterine massage) increased across all health
facilities by 19 percentage points from 2010 to 2012 (p <
0.001), largely due to increases in uterine massage (28.8
points) and CCT (15.5 points); there was little change in
uterotonic use (Table 2). However, a further analysis lim-
ited only to those women who received a uterotonic
reveals a significant improvement in the timing of its ad-
ministration: the proportion of women who received the
uterotonic on schedule (i.e., within 3 min after birth) in-
creased by 7.5 percentage points across all facilities (p =
0.003) (Fig. 2).
Lower-level health facilities made greater gains than
hospitals in the provision of all steps of AMTSL (47.2
percentage point increase versus 5.2 percentage points,
p < 0.001). Performance of CCT rose significantly (p <
0.001) by 15.5 percentage points across all levels of facil-
ities, with greater gains in hospitals (19.1 percentage
points, p < 0.001). The performance of uterine massage
following delivery of the placenta increased from 56.9 to
85.7% across all facility types (p < 0.001) (Table 2).
Substantial gains were made in oxytocin use at
lower-level facilities, rising from 58.1 to 95.2% of all
uterotonics used (p < 0.001). There was virtually no
change at hospitals because oxytocin use was already
universal in those facilities at baseline (Table 3).
Facility readiness to provide AMTSL: Availability of drugs
and service delivery guidelines
Figure 3 shows the availability of each type of uterotonic
in the facilities on the day of the study team’s visit. Gen-
erally, availability of the first choice uterotonic (oxytocin)
increased significantly (p < 0.001) across all facility types
from 73% of at baseline to 94% at the time of reassess-
ment in 2012. The increase was greater at lower-level fa-
cilities (from 53 to 87%) compared with hospitals (from
92 to 100%). In lower-level facilities the availability of
the second choice uterotonic, ergometrine, dropped by
43 percentage points (p < 0.001) and the availability of
misoprostol dropped by 14 percentage points (p < 0.001);
an increase in both was observed in hospitals (Fig. 3).
Out of the 52 health facilities surveyed in 2010, only
19 facilities (37%) had guidelines for uncomplicated de-
livery and 28 (54%) had guidelines for emergency obstet-
ric and newborn care. Following interventions under the
MAISHA program, both guidelines became more widely
available (p < 0.001): 44 of 50 health facilities surveyed in
2012 (88%) had guidelines for uncomplicated delivery
and 46 (92%) had guidelines for emergency obstetric and
newborn care (data not shown in the tables).
Discussion
The study’s findings showed that overall PPH prevention
practices improved significantly in hospitals and
lower-level health facilities for all three components of
AMTSL emphasized by the MAISHA program. The pro-
gram followed the original definition proposed by ICM
and FIGO [17], however, WHO’s current emphasis is on
the use of a uterotonic for prevention of PPH during the
third stage of labor [15, 17]. Although WHO recommen-
dations do not specify the timing, providing a uterotonic
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within 3 min of birth has been defined as a correct
AMTSL practice [18, 20, 23]. Our findings show a small
but significant improvement in timing for uterotonic
provision, although overall uterotonic use did not
change significantly. Any follow-up intervention should
consider the latest WHO recommendations, which also
include delayed cord clamping.
Health centers and dispensaries registered a significant
increase in use of oxytocin for PPH prevention com-
pared to other uterotonics. This was a desired change
since national guidelines recommend oxytocin as the
drug of choice for PPH. The study also documented sig-
nificant increases in the availability of oxytocin in health
centers and dispensaries as well as in its use for AMTSL.
These results are in accord with a study in India that
found the availability of oxytocin was associated with ad-
ministration of the drug for PPH prevention [24].
An observational study conducted in Tanzania in
2005—a few years before national PPH prevention and
management guidelines came into effect—concluded
that correct AMTSL practice, using the relaxed defin-
ition, was as low as 17% [19]. Much has changed since
then, including the adoption of oxytocin instead of ergo-
metrine in national policy and the establishment of
MoHCDGEC guidelines in 2008. These changes are
reflected in the 48.4% baseline measure of correct
AMTSL practice prior to the MAISHA intervention in
2010. The current study thus documents how a quality
improvement initiative can build on existing progress to
further strengthen the practice of AMTSL.
After the implementation of MAISHA program inter-
vention, the proportion of deliveries in which all
AMTSL steps were performed correctly rose from 41 to
60%. While this study was not designed to attribute
causality to the intervention, the findings strongly sug-
gest that MAISHA program activities yielded these im-
provements. This effect was especially pronounced at
lower-level health facilities, which had a greater need for
improvement.
Lower-level facilities in Tanzania have fewer health
care providers than hospitals, but they have lower staff
turnover. Turnover of trained staff has been reported to
adversely affect the quality of services provided in mater-
nal care [25]. This may help explain why lower-level fa-
cilities showed greater improvement than hospitals since
data collectors observed any provider conducting deliv-
eries, not just those who had received training from the
MAISHA program. Thus, the results at lower-level
facilities may reflect a more concentrated group of indi-
viduals exposed to MAISHA’s quality improvement
interventions.
Facility readiness to provide AMTSL, as measured by
the availability of guidelines and uterotonics, also im-
proved between the two assessments. Availability of
guidelines for uncomplicated delivery, which includes
national recommendations on AMTSL for prevention of
PPH, increased significantly from baseline to the 2012
assessment. Additionally, the availability of uterotonics
(particularly oxytocin) improved, with a significant in-
crease observed in health centers and dispensaries. This
Table 1 Description of deliveries observed at health facilities in 2010 and 2012
















Total number of deliveries observed 195 344 294 214 489 558
Number of deliveries with third stage of labor observed 164 311 251 191 415 502
Number of deliveries with third stage of labor observed and given any uterotonic 164 283 239 168 403 451
n number of health facilities
Table 2 Observed provision of AMTSL by level of health facility
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may be due to the emphasis on oxytocin as the first
choice uterotonic for PPH prevention and management,
in line with Tanzania’s guidelines [11]. The observed
changes at lower-level facilities is also likely to have re-
sulted from dissemination of PPH prevention and man-
agement policy guidelines to the facility level, improved
provider knowledge on timely ordering and stock man-
agement, as well as increased availability of uterotonics
in the labor room.
At the time the MAISHA program was being imple-
mented, the MoHCDGEC was implementing another pro-
gram that ensured that oxytocin was available for free at
national medical stores. This may have enabled health fa-
cilities to obtain sufficient oxytocin to meet their needs
even with constrained budgets. The improved availability
of uterotonics at study sites coincided with interventions
supported by the MAISHA program emphasizing timely
ordering of supplies by health facilities, which bridged the
gap between national policy and practice. This was an im-
portant intervention since studies have shown that incon-
sistent availability of uterotonics could negatively impact
the benefits of PPH prevention efforts [24]. Findings from
a multi-country survey conducted in 2012 by Smith et al.
indicated that the supply of oxytocin was problematic and,
in some countries, clients had to pay for oxytocin out of
pocket despite national policies to provide it to clients at
no cost [25].
An improvement in the availability of oxytocin—the
recommended first-line drug of choice—was observed in
both hospitals and lower-level health facilities. However,
availability increased more markedly in health centers
and dispensaries, where coverage was very low at base-
line. In surveyed hospitals, availability of oxytocin was
high at baseline and universal during the 2012 reassess-
ment. Increased availability of oxytocin should improve
the quality of care women receive when giving birth, as
was reported in a recent study in western Tanzania
where poor availability of essential commodities, such as
uterotonics, was one of the bottlenecks for improving
quality of care at birth [26].
Higher uterotonic coverage is expected at hospitals
than lower-level facilities because hospitals have a
stronger supply chain system and more qualified staff.
A survey of maternal health experts in Tanzania re-
ported that use of uterotonics immediately following
birth was almost universal in hospitals (at 99%),
whereas use in lower-level facilities was estimated at
less than three-quarters of all births [27], confirming
the results of this study.
Despite the widespread availability of oxytocin, some
women still did not receive a uterotonic within 3 min of
birth. Incorrect timing of administration of oxytocin for
AMTSL has been reported as one of the factors affecting
AMTSL practice in Tanzania [19]. A recent study of varia-
tions in care in Tanzania reported an association between
health workforce density and care at birth [26]; in a setting
with limited staff undertaking multiple tasks, staff may not
have enough time to follow the protocol. This could be
one of the contributing factors that prevented some
women from receiving appropriate uterotonic provision.
One of the study’s strengths was use of direct observa-
tion to assess provision of care. Direct observation
Fig. 2 Among women who received any uterotonic, proportion receiving it within 3 min of childbirth
Table 3 Type of uterotonic used for AMTSL by level of health facility
Uterotonic
type










































Misoprostol 0 (0) 1 (0.4) 0.4 0.27 26
(10.9)





N number of deliveries; n frequency
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overcomes self-report biases and gaps inherent in written
documentation. The study team does recognize that with
direct observations, the observer can have an effect on the
behavior of the person being observed. To strengthen the
study and reduce bias, inter-rater reliability measures were
applied during standardization of clinical observers.
Because this study was intended to serve as an evalu-
ation of the MAISHA program, the study was not de-
signed to be nationally representative and figures on
AMTSL provision should not be interpreted in this way.
Another potential limitation is that we did not collect
data on, or factor in the presence of, other concurrent
interventions that may have affected quality of intrapar-
tum care at study facilities. To our knowledge, however,
the MAISHA program was the only ministry-led na-
tional initiative that supported capacity building in
emergency obstetric and newborn care at the target fa-
cilities involved in the study. If there were other initia-
tives, they must have been ad hoc and very small scale,
making them unlikely to account for the overall im-
provement observed in this study.
In retrospect, the study could have utilized Mfinanga’s
estimation of prevalence of AMTSL using the relaxed
definition of AMSTL (17%) rather than estimation of
prevalence of AMTSL within one minute (7%) from the
same study [19]. Despite this, our estimation of AMTSL,
based on our sample, was sufficient to achieve statistical
significance. Finally, as a cross-sectional study, the data
collected on availability of uterotonics did not reflect the
history of stock-outs in each facility but rather provided
an indication of stock status at a particular moment in
time. We believe that despite the limitations, the find-
ings provide considerable insight into health care pro-
vider practice around PPH prevention in Tanzania.
Further research is recommended to investigate the
wider outcomes and impacts of improvements in AMTSL
practices and the availability of oxytocin. A follow-up
study at the same study facilities could investigate whether
the gains described here have led to improvements in
other EmOC signal functions or helped reduce maternal
mortality and morbidity at the facility level.
Conclusion
As Tanzania continues to promote facility births, it is im-
perative that quality of care during labor and delivery at the
facility be improved. AMTSL has the potential to decrease
the incidence of PPH, one of the leading causes of maternal
death in Tanzania and other LMICs. For AMTSL to be ef-
fective, however, it must be performed correctly, following
all the recommended steps. The results of this study sug-
gest that this can be achieved by developing and rolling out
high-quality, up-to-date, evidence-based guidelines for care
of women during labor and delivery. This study also sug-
gests that concentrated quality improvement efforts can
contribute to positive changes in PPH prevention practices
among health care providers.
This study demonstrated significant improvement in
the practice of AMTSL two years after the intervention,
with low-level facilities showing greater gains than hos-
pitals. Meaningful change at service delivery points can
be brought about by implementation of existing and new
guidelines and protocols. Routine measurement of the
correct practice of AMTSL among providers of care dur-
ing labor and delivery can be extremely helpful in moni-
toring PPH prevention at the facility level.
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